SCHEMBL15315409

SCHEMBL15315409

CCN(CC)c1ccc(/C=N/NC(=O)c2ccc(CO)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.77
ALDH1A1 P00352 11/20 0.77
KDM4E B2RXH2 10/20 0.77
KMT2A Q03164 5/20 0.77
ESRRG P62508 4/20 0.77
MEN1 O00255 4/20 0.77
HPGD P15428 2/20 0.77
HDAC6 Q9UBN7 2/20 0.77
TP53 P04637 1/20 0.77
CYP3A4 P08684 1/20 0.77
ALOX15 P16050 1/20 0.77
TSHR P16473 1/20 0.77
CASP1 P29466 1/20 0.77
HSD17B10 Q99714 1/20 0.77
RAB9A P51151 8/20 0.64
NPC1 O15118 6/20 0.64
SMN1; SMN2 Q16637 4/20 0.64
GAA P10253 5/20 0.62
GFER P55789 2/20 0.62
GLA P06280 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131315 0.87 MAPT (1.00) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL1131313 0.87 MAPT (1.00) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL1129782 0.87 MAPT (1.00) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL15315413 0.86 MAPT (0.79) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL15315410 0.86 ESRRG (1.00) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL2536737 0.84 MAPT (0.76) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL8243886 0.84 MAPT (0.76) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL12443591 0.84 ESRRG (0.77) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL8771803 0.82 ESRRG (0.74) MAPTALDH1A1KDM4EKMT2AESRRG
SCHEMBL12793798 0.77 ALDH1A1 (0.75) MAPTALDH1A1KDM4EKMT2AESRRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130274233-A1 MODULATORS OF HEDGEHOG SIGNALING PATHWAY PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274233-A1 MODULATORS OF HEDGEHOG SIGNALING PATHWAY GLI1, SMO, SHH MAPT 2947/4885ALDH1A1 3537/4885KDM4E 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.